EFFICACY AND SAFETY OF OLORINAB, A PERIPHERALLY ACTING, HIGHLY SELECTIVE, FULL AGONIST OF CANNABINOID RECEPTOR 2, FOR THE TREATMENT OF ABDOMINAL PAIN IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: RESULTS FROM A PHASE 2B RANDOMIZED STUDY

Brooks D Cash  1     Anthony J. Lembo  2     David C. Kunkel  3     Brett A. English  4     Beatriz Lindstrom  4     Sharon Skare  5     Charlie Liu     Stewart Turner     Fabio Cataldi     Saleem Desai     Donald Lipkis     Jan Tack     Lin Chang    
1 University of Texas Health Science Center Houston,Houston,United States
2 Beth Israel Deaconess Medical Center,Boston,United States
3 University of California San Diego,La Jolla,United States
4 Arena Pharmaceuticals, Inc.,San Diego,United States
5 Arena Pharmaceuticals, Inc.,San Diego,U

Session
IBS

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing